An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome



Status:Archived
Conditions:Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:July 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The record Primary purpose is to assess the efficacy of eculizumab in adult patients with
aHUS to control TMA as characterized by thrombocytopenia, hemolysis and renal impairment.



We found this trial at
4
sites
Clinical Trial Facility
Medford, Oregon
?
mi
from
Medford, OR
Click here to add this to my saved trials
Clinical Trial Facility
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials
Clinical Trial Facility
Boston, Massachusetts
?
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial Facility
Lima, Ohio
?
mi
from
Lima, OH
Click here to add this to my saved trials